57 results
Page 2 of 3
425
c0xx 7v2lae6sc6vym
5 May 21
Business combination disclosure
5:26pm
425
nwxt25
5 May 21
Business combination disclosure
5:24pm
6-K
EX-99.5
qcg9pw1mn9fzs3 dbczi
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.1
pcoebsdkpbqjlhdnz4u
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.1
rk9qh zwtqlyx
5 May 21
Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases
8:45am
20-F
EX-2.7
f5zndyqh
30 Apr 21
Annual report (foreign)
12:53pm
20-F
ggw9mh1qbgv
30 Apr 21
Annual report (foreign)
12:53pm
424B3
eaow2h6wjj9aleoehvn9
4 Mar 21
Prospectus supplement
8:38am
6-K
EX-99.1
o7qvy pym07va5mmsrs
4 Mar 21
Amryt Announces Record FY 2020 Results
8:20am
424B4
j89el78uf2btlysv
14 Jan 21
Prospectus supplement with pricing info
9:30am
F-1/A
5gc7pzw7mrwzv8m
12 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1
0fb7cr0v
8 Jan 21
Registration statement (foreign)
4:58pm
DRS
bfq8cuzk
18 Dec 20
Draft registration statement
12:00am
6-K
4vuh95n
9 Dec 20
Current report (foreign)
4:23pm
6-K
EX-99.1
nattkuhc872
9 Dec 20
Amryt Group Receives Marketing Authorisation Approval for Lojuxta® in Brazil
6:30am
6-K
EX-99.1
9201c8l jpnnct
8 Dec 20
Amryt Announces $40m Private Placement with Leading Biotech Investors
6:05am
6-K
EX-99.1
80qsz xcoxx
3 Nov 20
Current report (foreign)
8:45am
424B4
lbyqnk8xmay
8 Jul 20
Prospectus supplement with pricing info
4:05pm
F-1/A
qm0n6nbt bpi
7 Jul 20
Registration statement (foreign) (amended)
5:02pm
F-1/A
3lex9e0
6 Jul 20
Registration statement (foreign) (amended)
5:28pm